• 16 February 2018

    Broad Institute in US enhances SHERLOCK diagnostic tool

    Researchers at the Broad Institute of MIT and Harvard in the US have improved their CRISPR-based diagnostic tool called SHERLOCK to feature higher sensitivity and capability to simultaneously detect various...

  • 15 February 2018

    LivaNova signs agreement to buy TandemLife for $250m

    UK-based LivaNova has entered an agreement to purchase US-based TandemLife for a total consideration of up to $250m, including $200m upfront and $50m contingent considerations for regulatory milestones.

  • 15 February 2018

    BD gets FDA approval for new human papillomavirus test

    Becton Dickinson (BD) has obtained pre-market approval from the US Food and Drug Administration (FDA) for the BD Onclarity HPV assay designed to screen human papillomavirus (HPV) genotypes associated with...